What is the generic version of Byetta?
Byetta is a brand name medication used to treat type 2 diabetes. The generic version of Byetta is called Exenatide. Exenatide is an injectable medication that works by stimulating the release of insulin from the pancreas and reducing the release of glucagon.
When is the Byetta patent set to expire?
The Byetta patent was held by Eli Lilly and Company and Amylin Pharmaceuticals. However, in 2016, Eli Lilly acquired Amylin Pharmaceuticals, gaining full ownership of the Byetta patent. According to DrugPatentWatch.com [1], the Byetta patent held by Eli Lilly is set to expire on February 18, 2026.
What companies make generic versions of Byetta?
Following the patent expiration, multiple companies will likely start manufacturing generic versions of Byetta. According to the patent data provided by DrugPatentWatch.com [1], at least two companies, Teva and Lupin, have filed for approval with the FDA to market generic versions of Exenatide.
What side effects are patients asking about?
Exenatide, the generic version of Byetta, may have similar side effects to the brand name medication. According to the FDA labeling, common side effects of Exenatide include nausea, vomiting, diarrhea, abdominal pain, and low blood sugar. In rare cases, Exenatide may also cause pancreatitis, thyroid tumors, and allergic reactions.
What is the price of generic Byetta compared to the brand name?
Generic medications like Exenatide are often significantly cheaper than their brand name counterparts. According to GoodRx [2], a pharmacy cost comparison website, the price of generic Exenatide can range from $300 to $500 per month, depending on the pharmacy and location. In comparison, the brand name Byetta can cost upwards of $1,000 per month.
When can biosimilars enter the market?
Biosimilars are highly similar versions of biologic medications like Byetta. According to the Biologics Price Competition and Innovation Act of 2009, biosimilars can enter the market after the originator medication's patent expires. However, biosimilars must undergo rigorous clinical testing to demonstrate their safety and efficacy.
Can patients switch to generic Byetta safely?
Patients can switch from brand name Byetta to generic Exenatide safely. However, it's essential to consult with a healthcare provider before making any medication changes. They can ensure that the switch will not disrupt the patient's treatment plan and that they understand any potential differences between the brand name and generic versions.
Sources:
[1] DrugPatentWatch.com (Drug Patent Expiration Date for Byetta)
[2] GoodRx (Generic Exenatide Price Comparison)
[3] Exenatide FDA Labeling